Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr Luca Santarelli named head of CNS discovery and translational area at Roche

This article was originally published in Scrip

Executive Summary

Roche has named Dr Luca Santarelli head of the central nervous system (CNS) discovery and translational area (DTA). The CNS DTA is one of five disease-focused organisations at Roche and oversees R&D in the field of neurology/neurosciences. Since 2007, Dr Santarelli has been the global head of neuroscience, clinical research and early development. He joined Roche in 2005, and has helped progress five internal and partnered programmes to Phase II development in schizophrenia, Alzheimer's disease, multiple sclerosis, treatment-resistant depression and fragile X, and one schizophrenia trial to late-stage development.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts